LIDOCAINA 2% CON EPINEFRINA 1:200 000 SIN PRESERVANTE 2% SOLUCION INYECTABLE Peru - espanja - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

lidocaina 2% con epinefrina 1:200 000 sin preservante 2% solucion inyectable

laboratorios unidos s.a. - epinefrina; clorhidrato de lidocaina; - solucion inyectable - por vial ml; epinefrina 0.000100 g; clorhidrato de lidocaina 0.400000 g; - lidocaÍna, combinaciones

Blenrep Euroopan unioni - espanja - EMA (European Medicines Agency)

blenrep

glaxosmithkline (ireland) limited - belantamab mafodotin - mieloma múltiple - agentes antineoplásicos - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.